· You
may lose some or all of your investment. If the final index level is less than the barrier level, the contingent
repayment of the stated principal amount at maturity will not apply and you will lose 1% of the stated principal amount
of the securities for every 1% by which the final index level is less than the initial index level. The securities offer
no protection at all if the underlying index depreciates by more than 29.15%.
· The
securities do not pay interest.
· Investing
in the securities is not equivalent to investing in the underlying index or the stocks that constitute the underlying
index. You will not have voting rights, rights to receive dividends or any other rights with respect to the stocks that
constitute the underlying index.
· The
securities are subject to the credit risk of Citigroup Inc. If Citigroup Inc. defaults on its obligations under the securities,
you may not receive anything owed to you under the securities.
· The
securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.
· The
estimated value of the securities on the pricing date will be less than the issue price. For more information about the
estimated value of the securities, see the accompanying preliminary pricing supplement.
· The
value of the securities prior to maturity is likely to be less than the issue price and will fluctuate based on many unpredictable
factors.
· Citigroup
Inc. and its affiliates, and the placement agents and their affiliates, may have conflicts of interest with you.
· The
U.S. federal tax consequences of an investment in the securities are unclear.
The above summary
of selected risks does not describe all of the risks associated with an investment in the securities. You should read
the accompanying preliminary pricing supplement and product supplement for a more complete description of risks relating
to the securities.
Citigroup Inc. has
filed a registration statement (including the accompanying preliminary pricing supplement, product supplement, underlying
supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission (“SEC”) for
the offering to which this communication relates. Before you invest, you should read the accompanying preliminary pricing
supplement, product supplement, underlying supplement, prospectus supplement and prospectus in that registration statement
(File No. 333-192302) and the other documents Citigroup Inc. has filed with the SEC for more complete information about
Citigroup Inc. and this offering. You may obtain these documents without cost by visiting EDGAR on the SEC website at
www.sec.gov. Alternatively, you can request these documents by calling toll-free 1-800-831-9146. |